Two IPOs are scheduled to raise $1.3 billion in the week ahead. While the IPO calendar is relatively quiet at the moment, several issuers could launch, including pool equipment supplier Hayward Holdings (HAYW) and crafts-focused companies Cricut (CRCT) and JOANN (JOAN). Online health insurer ...read more
Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, raised $221 million by offering 13.8 million shares at $16, the high end of the $14 to $16 range. Talis originally filed to sell 10 million shares, before increasing the offering to 11.5 million shares on Thursday, and further upsizing the deal at pricing.
Talis's IPO follows that...read more
The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. The IPO pipeline remained active as well, with 3 IPOs and 38 SPACs submitting initial filings. TELUS International (TIXT) upsized and priced at the high end to raise $925 million at a $6.6 billion market cap. The company provides outsourced...read more
Lucira Health, which is developing single-use test kits for COVID-19 and other infectious diseases, raised $153 million by offering 9 million shares at $17, the high end of the range of $15 to $17. The company previously planned to offer 7.8 million shares. At $17, Lucira commands a fully diluted market cap of $705 million. Lucira Health plans to list on the Nasdaq under the...read more
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
US IPO Week Ahead: Health insurer Oscar Health leads a 2 IPO week
Two IPOs are scheduled to raise $1.3 billion in the week ahead. While the IPO calendar is relatively quiet at the moment, several issuers could launch, including pool equipment supplier Hayward Holdings (HAYW) and crafts-focused companies Cricut (CRCT) and JOANN (JOAN). Online health insurer ...read more
COVID-19 test developer Talis Biomedical prices upsized IPO at $16 high end
Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, raised $221 million by offering 13.8 million shares at $16, the high end of the $14 to $16 range. Talis originally filed to sell 10 million shares, before increasing the offering to 11.5 million shares on Thursday, and further upsizing the deal at pricing. Talis's IPO follows that...read more
US IPO Weekly Recap: Biotechs flood the IPO market in a 14 IPO week
The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. The IPO pipeline remained active as well, with 3 IPOs and 38 SPACs submitting initial filings. TELUS International (TIXT) upsized and priced at the high end to raise $925 million at a $6.6 billion market cap. The company provides outsourced...read more
COVID-19 test kit developer Lucira Health prices upsized IPO at $17 high end
Lucira Health, which is developing single-use test kits for COVID-19 and other infectious diseases, raised $153 million by offering 9 million shares at $17, the high end of the range of $15 to $17. The company previously planned to offer 7.8 million shares. At $17, Lucira commands a fully diluted market cap of $705 million. Lucira Health plans to list on the Nasdaq under the...read more